EU Reg 2026/909 Just Reset 12 Ingredients on May 18 — Triphenyl Phosphate Banned, Benzyl Salicylate Restricted

Commission Regulation (EU) 2026/909 entered into force on 18 May 2026, amending the EU Cosmetics Regulation across 12 ingredients. This is a separate instrument from Omnibus VIII (Reg 2026/78, covered 17 May) and from the 82-allergen disclosure framework — it sits on its own timeline and hits a different formulary surface. Trade compliance summaries tied to the regulation include a ban on triphenyl phosphate and revised restrictions or specifications for substances including benzyl salicylate, citral, water-soluble zinc salts, acetylated vetiver oil, and the UV filter DHHB.

The transition structure is what matters operationally: covered non-compliant products can no longer be newly placed on the EU market from January 1, 2027, with full withdrawal deadlines later in 2028. That's a roughly seven-month runway for new launches and an 18-month runway for sell-through. For brands with multi-region SKU planning, the calendar is now: Omnibus VIII already binding, Reg 2026/909 placement deadline January 2027, EU 82-allergen disclosure July 2026, withdrawal under 909 in 2028. Four overlapping clocks, not one.

The deeper signal — and the analyst read worth keeping — is that 'clean' is being converted into a regulator-defined operating standard. Brands that still treat clean as a retailer questionnaire instead of a formulation roadmap are about to discover the gap between a merchandising claim and a legal timetable. The likely outcome is more dual-formula planning, more retailer compliance scrutiny, and less tolerance for fragrance- and filter-heavy formulas still being sold as if exclusion-list debates were the main event.

For US-only brands the temptation is to file this away. That is the wrong instinct. EU regulation increasingly sets the de facto global formulary because contract manufacturers won't run two parallel batch processes for the same SKU. When DHHB is restricted in the EU, it becomes harder to source at scale anywhere; when benzyl salicylate is reformulated out of European fragrance houses, the US-bound version often follows within a year because the supplier has moved on.